EUVIMEDEUVIMED entdecken
Crossref

Cough-Variant Asthma: Pathobiology, Clinical Phenotyping, Diagnosis, and Evidence-Based Treatment Approaches

Ahmet AKCAN

Uluslararası Sağlık Bilimlerinde Disiplinler Arası Etkileşim Dergisi · 2026

DOI: 10.65349/wvys5659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Uluslararası Sağlık Bilimlerinde Disiplinler Arası Etkileşim Dergisi, 2026. Verfasst von Ahmet AKCAN. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate current evidence on the pathobiology, clinical features, diagnostic approach, differential diagnosis, treatment, and prognosis of cough-variant asthma (CVA) within an integrated framework applicable to clinical practice.

Methods

For this structured narrative review, PubMed/MEDLINE was searched from inception through September 1, 2026. Documents from the European Respiratory Society, CHEST, and the Global Initiative for Asthma, together with the reference lists of selected studies, were also reviewed. Priority was given to clinical guidelines, systematic reviews, prospective cohorts, diagnostic-accuracy studies, and randomized controlled trials. No formal risk-of-bias assessment or quantitative data synthesis was performed.

Results

CVA is a biologically heterogeneous asthma phenotype in which cough is the sole or predominant manifestation. Normal baseline spirometry does not exclude the diagnosis. Diagnostic evaluation requires integrated interpretation of a compatible clinical pattern, objective evidence of variable expiratory airflow limitation or airway hyperresponsiveness, and reasonable exclusion of alternative causes. Fractional exhaled nitric oxide, blood eosinophil count, and induced-sputum eosinophilia may support the identification of type 2 inflammation but are not diagnostic in isolation. Inhaled corticosteroids are the cornerstone of treatment. When the response is inadequate, the diagnosis, inhaler technique, adherence, exposures, and comorbidities should be reassessed before treatment escalation. Direct CVA-specific evidence remains limited, particularly regarding pediatric patients, long-term prognosis, and treatment duration.

Conclusion

The diagnosis of CVA should not be based on a single test, biomarker, or therapeutic response; clinical, physiological, and inflammatory findings should be evaluated collectively. Standardized diagnostic criteria and long-term randomized controlled trials are needed.

Zitieren

APA

AKCAN, A. (2026). Cough-Variant Asthma: Pathobiology, Clinical Phenotyping, Diagnosis, and Evidence-Based Treatment Approaches. Uluslararası Sağlık Bilimlerinde Disiplinler Arası Etkileşim Dergisi. https://doi.org/10.65349/wvys5659

Vancouver

AKCAN A. Cough-Variant Asthma: Pathobiology, Clinical Phenotyping, Diagnosis, and Evidence-Based Treatment Approaches. Uluslararası Sağlık Bilimlerinde Disiplinler Arası Etkileşim Dergisi. 2026. doi:10.65349/wvys5659

BibTeX
@article{AKCAN2026,
  author = {AKCAN, Ahmet},
  title = {Cough-Variant Asthma: Pathobiology, Clinical Phenotyping, Diagnosis, and Evidence-Based Treatment Approaches},
  journal = {Uluslararası Sağlık Bilimlerinde Disiplinler Arası Etkileşim Dergisi},
  year = {2026},
  doi = {10.65349/wvys5659}
}
Kostenlos starten →